AIDS patients demand drugs as government hesitates.
作者信息
Jayaraman K S
出版信息
Nat Med. 1997 Sep;3(9):943. doi: 10.1038/nm0997-943a.
PMID:9288710
Abstract
摘要
相似文献
1
AIDS patients demand drugs as government hesitates.
Nat Med. 1997 Sep;3(9):943. doi: 10.1038/nm0997-943a.
2
Indian company seeks US approval for generic AIDS drugs.
Nature. 2004 Aug 12;430(7001):716. doi: 10.1038/430716a.
3
AIDS buyers' clubs.
Am J Health Syst Pharm. 1997 Sep 15;54(18):2122-4. doi: 10.1093/ajhp/54.18.2122.
4
AIDS costs remain problematic despite improvements in therapy.
Capitation Rates Data. 1998 Sep;3(9):101-3.
5
Indian company offers low cost AIDS drugs.
Lancet. 2001 Feb 24;357(9256):616. doi: 10.1016/S0140-6736(05)71411-2.
6
[Clinical and economic impact of new antiretroviral treatments].
Rev Clin Esp. 1999 Feb;199(2):53-4.
7
[HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
MMW Fortschr Med. 2014 Jun 12;156 Suppl 1:62-3.
8
A multidisciplinary approach to scaling up HIV/AIDS treatment and care: the experience of the Bahamas.
Rev Panam Salud Publica. 2005 Jan;17(1):66-72. doi: 10.1590/s1020-49892005000100012.
9
AIDS funds: undervalued.
Science. 2010 Oct 8;330(6001):174-5; author reply 177-8. doi: 10.1126/science.330.6001.174-b.
10
Helping with the high cost of living with AIDS.
Contemp Longterm Care. 1997 Jan;20(1):48.
Zotero 插件